The association between abnormal heart rate variability and new onset of chronic kidney disease in patients with type 2 diabetes: A ten-year follow-up study

Diabetes Research and Clinical Practice

Volumn 108, Issue 1, 2015, Pages 31-37

  Yun, Jae Seung ^a   Ahn, Yu Bae ^a   Song, Ki Ho ^b   Yoo, Ki Dong ^a   Kim, Hyung Wook ^a   Park, Yong Moon ^c   Ko, Seung Hyun ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cardiovascular autonomic neuropathy; Chronic kidney disease; Heart rate variability; Type 2 diabetes

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ABNORMAL HEART RATE VARIABILITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASSESSMENT OF HUMANS; CARDIOVASCULAR AUTONOMIC FUNCTION TEST; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC CARDIOVASCULAR AUTONOMIC NEUROPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; FUNCTION TEST; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INSULIN TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETES COMPLICATIONS; FORECASTING; HEART RATE; INCIDENCE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SOUTH KOREA;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEART RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA;

EID: 84926186604     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2015.01.031     Document Type: Article

References (42)

1. Ahn J.H., Yu J.H., Ko S.H., Kwon H.S., Kim D.J., Kim J.H., et al. Prevalence and determinants of diabetic nephropathy in Korea: Korea national health and nutrition examination survey. Diabetes Metab J 2014, 38:109-119.
2. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diabetes Rep 2006, 6:479-483.
3. Lopes A.A. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations. Ethn Dis 2009, 19. S1-47-S1-51.
4. Jin D.C. Current status of dialysis therapy in Korea. Korean J Intern Med 2011, 26:123-131.
5. Park C.W. Diabetic kidney disease: from epidemiology to clinical perspectives. Diabetes Metab J 2014, 38:252-260.
6. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010, 33:434-441.
7. Valensi P., Paries J., Attali J.R. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications - the French multicenter study. Metabolism 2003, 52:815-820.
8. Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007, 115:387-397.
9. Maguire A.M., Craig M.E., Craighead A., Chan A.K., Cusumano J.M., Hing S.J., et al. Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care 2007, 30:77-82.
10. Molgaard H., Christensen P.D., Sorensen K.E., Christensen C.K., Mogensen C.E. Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients. Diabetes 1992, 41:812-817.
11. Spallone V., Gambardella S., Maiello M.R., Barini A., Frontoni S., Menzinger G. Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care 1994, 17:578-584.
12. Sundkvist G., Lilja B. Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM. Diabetes Care 1993, 16:773-779.
13. Zander E., Schulz B., Heinke P., Grimmberger E., Zander G., Gottschling H.D. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy. Diabetes Care 1989, 12:259-264.
14. Bertog S.C., Sobotka P.A., Sievert H. Renal denervation for hypertension. JACC Cardiovasc Interv 2012, 5:249-258.
15. Moran A., Palmas W., Field L., Bhattarai J., Schwartz J.E., Weinstock R.S., et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 2004, 27:972-977.
16. Weinrauch L.A., Kennedy F.P., Gleason R.E., Keough J., D'Elia J.A. Relationship between autonomic function and progression of renal disease in diabetic proteinuria: clinical correlations and implications for blood pressure control. Am J Hypertens 1998, 11:302-308.
17. Ko S.H., Kwon H.S., Kim D.J., Kim J.H., Kim N.H., Kim C.S., et al. Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth Korean National Health and Nutrition Examination Survey in 2011. Diabetes Metab J 2014, 38:51-57.
18. Spallone V., Ziegler D., Freeman R., Bernardi L., Frontoni S., Pop-Busui R., et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 2011, 27:639-653.
19. Yun J.S., Kim J.H., Song K.H., Ahn Y.B., Yoon K.H., Yoo K.D., et al. Cardiovascular autonomic dysfunction predicts severe hypoglycemia in patients with Type 2 diabetes mellitus: a ten-year follow-up study. Diabetes Care 2013, 37:235-241.
20. Levey A.S., Eckardt K.U., Tsukamoto Y., Levin A., Coresh J., Rossert J., et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 2005, 67:2089-2100.
21. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
22. Standards of medical care in diabetes - 2014. Diabetes Care 2014, 37(Suppl. 1):S14-S80.
23. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
24. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis 2012, 60:850-886.
25. Grambsch P. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994, 1994:515-526.
26. Levey A.S., Inker L.A., Coresh J. GFR estimation from physiology to public health. Am J Kidney Dis 2014, 63:820-834.
27. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and, stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-S266.
28. de Boer I.H., Rue T.C., Hall Y.N., Heagerty P.J., Weiss N.S., Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA 2011, 305:2532-2539.
29. Hemmelgarn B.R., Manns B.J., Lloyd A., James M.T., Klarenbach S., Quinn R.R., et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010, 303:423-429.
30. Matsushita K., van der Velde M., Astor B.C., Woodward M., Levey A.S., de Jong P.E., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
31. Lou Q.L., Ouyang X.J., Gu L.B., Mo Y.Z., Ma R., Nan J., et al. Chronic kidney disease and associated cardiovascular risk factors in Chinese with type 2 diabetes. Diabetes Metab J 2012, 36:433-442.
32. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69:2057-2063.
33. U.S.Renal Data System USRDS 2013 Annual Data Report: atlas of chronic kidney disease and end-stage renal disease in the United States 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, [accessed 22.06.14]. http://www.usrds.org/2013/pdf/v2_ch12_13.pdf.
34. Hailpern S.M., Melamed M.L., Cohen H.W., Hostetter T.H. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2007, 18:2205-2213.
35. James M.T., Quan H., Tonelli M., Manns B.J., Faris P., Laupland K.B., et al. CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 2009, 54:24-32.
36. Wilhelm-Leen E.R., Hall Y.N., Chertow M.K.T.G.M. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med 2009, 122. 664-671.e2.
37. Ensrud K.E., Lui L.Y., Taylor B.C., Ishani A., Shlipak M.G., Stone K.L., et al. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007, 167:133-139.
38. Molitch M.E., Adler A.I., Flyvbjerg A., Nelson R.G., So W.Y., Wanner C., et al. Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes. Kidney Int 2015, 87:20-30.
39. Qaseem A., Hopkins R.H., Sweet D.E., Starkey M., Shekelle P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2013, 159:835-847.
40. Barajas L. Innervation of the renal cortex. Fed Proc 1978, 37:1192-1201.
41. Vinik A.I., Maser R.E., Mitchell B.D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
42. Ali O., Mohiuddin A., Mathur R., Dreyer G., Hull S., Yaqoob M.M. A cohort study on the rate of progression of diabetic chronic kidney disease in different ethnic groups. BMJ Open 2013, 3.